Ex-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCT

Clinical trial NCT05066958 · UNKNOWN

Trial details

NCT number: NCT05066958
Sponsor: Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia High Risk Acute Myeloid Leukemia Acute Lymphoblastic Leukemia, in Relapse High Risk Acute Lymphoblastic Leukemia Acute Biphenotypic Leukemia in Relapse Non-hodgkin Lymphoma Myelodysplastic Syndromes

Start date: 2021-09-16
Primary completion: 2022-09-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.